Ellen M. Mowry

18.2k total citations
152 papers, 5.6k citations indexed

About

Ellen M. Mowry is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Ellen M. Mowry has authored 152 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pathology and Forensic Medicine, 31 papers in Neurology and 26 papers in Immunology. Recurrent topics in Ellen M. Mowry's work include Multiple Sclerosis Research Studies (103 papers), Peripheral Neuropathies and Disorders (16 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers). Ellen M. Mowry is often cited by papers focused on Multiple Sclerosis Research Studies (103 papers), Peripheral Neuropathies and Disorders (16 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers). Ellen M. Mowry collaborates with scholars based in United States, Spain and Canada. Ellen M. Mowry's co-authors include Emmanuelle Waubant, Daniel Pelletier, Kathryn C. Fitzgerald, Pavan Bhargava, Darin T. Okuda, Peter A. Calabresi, Douglas S. Goodin, Jonathan B. Strober, Dorothée Chabas and Peter Bacchetti and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and NeuroImage.

In The Last Decade

Ellen M. Mowry

147 papers receiving 5.5k citations

Peers

Countries citing papers authored by Ellen M. Mowry

Since Specialization

Citations

This map shows the geographic impact of Ellen M. Mowry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen M. Mowry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen M. Mowry more than expected).

Fields of papers citing papers by Ellen M. Mowry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen M. Mowry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen M. Mowry. The network helps show where Ellen M. Mowry may publish in the future.

Co-authorship network of co-authors of Ellen M. Mowry

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen M. Mowry. A scholar is included among the top collaborators of Ellen M. Mowry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen M. Mowry. Ellen M. Mowry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White Americans 2024 ·Multiple Sclerosis Journal ·Farren Briggs, Devon Conway, Carrie M. Hersh, Kathryn C. Fitzgerald, Ellen M. Mowry, Jeffrey A. Cohen, Daniel Ontaneda	2
2	A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS 2023 ·Neurotherapeutics ·Scott D. Newsome, Fan Tian, (unknown), Kathryn C. Fitzgerald, Sandra D. Cassard, (unknown), (unknown), David S. Cooper, Jennifer S. Mammen, Pavan Bhargava, Ellen M. Mowry, Peter A. Calabresi	2
3	Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial 2023 ·Multiple Sclerosis and Related Disorders ·Mitzi Williams, (unknown), Anne H. Cross, Nancy Monson, Timothy Vartanian, Ben Thrower, Anthony T. Reder, (unknown), Gregory F. Wu, Evanthia Bernitsas, (unknown), (unknown), Jinglan Pei, Ellen M. Mowry, Fabio Magrini, (unknown), Lilyana Amezcua	8
4	Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis 2023 ·Neurology ·Elias S. Sotirchos, (unknown), Matthew D. Smith, (unknown), Anna DuVal, Georgina Arrambide, Xavier Montalbán, Katja Akgün, Tjalf Ziemssen, Robert T. Naismith, Carrie M. Hersh, Megan Hyland, Lauren Krupp, Jacqueline Nicholas, Robert A Bermel, Ellen M. Mowry, Peter A. Calabresi, Kathryn C. Fitzgerald	6
5	Improving the efficiency of clinical trials in multiple sclerosis 2023 ·Multiple Sclerosis Journal ·Ruth Ann Marrie, Maria Pia Sormani, (unknown), Francesca Bovis, Winson Y. Cheung, Gary Cutter, Peter Feys, Michael D. Hill, Marcus Koch, Morgan McCreary, Ellen M. Mowry, Jay Park, Fredrik Piehl, Amber Salter, Jeremy Chataway	10
6	Serum Sickness/Serum Sickness–like Reactions Following Ocrelizumab Infusion in 2 Patients With Multiple Sclerosis 2023 ·International Journal of MS Care ·(unknown), Bardia Nourbakhsh, Ellen M. Mowry	1
7	Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease 2022 ·Neurology ·Paula Barreras, Eleni S. Vasileiou, Angeliki Filippatou, Kathryn C. Fitzgerald, Michael Levy, Carlos A. Pardo, Scott D. Newsome, Ellen M. Mowry, Peter A. Calabresi, Elias S. Sotirchos	49
8	Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis 2022 ·Neurology ·Elias S. Sotirchos, Eleni S. Vasileiou, Angeliki Filippatou, Kathryn C. Fitzgerald, Matthew D. Smith, (unknown), Grigorios Kalaitzidis, Jeffrey Lambe, Anna DuVal, Jerry L. Prince, Ellen M. Mowry, Shiv Saidha, Peter A. Calabresi	8
9	Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis 2022 ·Neurology Neuroimmunology & Neuroinflammation ·Eleni S. Vasileiou, (unknown), Çharles N. Bernstein, Fred Lublin, Jerry S. Wolinsky, Gary Cutter, Elias S. Sotirchos, Kaarina Kowalec, Amber Salter, Shiv Saidha, Ellen M. Mowry, Peter A. Calabresi, Ruth Ann Marrie, Kathryn C. Fitzgerald	4
10	Demographics and Baseline Disease Characteristics of Black and Hispanic Patients With Multiple Sclerosis in the CHIMES Trial (P4-4.005) 2022 ·Neurology ·Lilyana Amezcua, (unknown), Anne H. Cross, Nancy Monson, Ben Thrower, Anthony T. Reder, (unknown), Gregory F. Wu, Evanthia Bernitsas, (unknown), (unknown), Jinglan Pei, Ellen M. Mowry, Fabio Magrini, Mitzi Williams	1
11	Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism 2021 ·Cell Reports Medicine ·Kathryn C. Fitzgerald, Matthew D. Smith, Sol Kim, Elias S. Sotirchos, Michael D. Kornberg, (unknown), Bardia Nourbakhsh, Jennifer Graves, Ramandeep Rattan, Laila Poisson, Mirela Cerghet, Ellen M. Mowry, Emmanuelle Waubant, Shailendra Giri, Peter A. Calabresi, Pavan Bhargava	50
12	Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD 2020 ·Multiple Sclerosis Journal ·Angeliki Filippatou, Eleni S. Vasileiou, Yufan He, Kathryn C. Fitzgerald, Grigorios Kalaitzidis, Jeffrey Lambe, Maureen A. Mealy, Michael Levy, Yihao Liu, Jerry L. Prince, Ellen M. Mowry, Shiv Saidha, Peter A. Calabresi, Elias S. Sotirchos	24
13	Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis 2020 ·Multiple Sclerosis Journal ·Angeliki Filippatou, Jeffrey Lambe, Elias S. Sotirchos, Kathryn C. Fitzgerald, (unknown), Olwen C. Murphy, (unknown), (unknown), (unknown), Esther Ogbuokiri, Ohemaa Kwakyi, (unknown), (unknown), Nicholas J. Luciano, Ciprian M. Crainiceanu, Jerry L. Prince, Ellen M. Mowry, Peter A. Calabresi, Shiv Saidha	22
14	Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis 2019 ·Multiple Sclerosis Journal ·Elias S. Sotirchos, (unknown), Blake E. Dewey, Kathryn C. Fitzgerald, Jeffrey Glaister, Angeliki Filippatou, Esther Ogbuokiri, (unknown), Ohemaa Kwakyi, (unknown), Ciprian M. Crainiceanu, Dzung L. Pham, Peter C. van Zijl, Ellen M. Mowry, Daniel S. Reich, Jerry L. Prince, Peter A. Calabresi, Shiv Saidha	30
15	Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness 2018 ·Multiple Sclerosis Journal ·Angeliki Filippatou, (unknown), Megan Esch, (unknown), (unknown), Jerry L. Prince, Ellen M. Mowry, Peter A. Calabresi, Shiv Saidha, Elias S. Sotirchos	12
16	The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease 2017 ·Neurologic Clinics ·Ellen M. Mowry, Justin D. Glenn	33
17	Emerging Concepts on the Gut Microbiome and Multiple Sclerosis 2016 ·Journal of Interferon & Cytokine Research ·Justin D. Glenn, Ellen M. Mowry	24
18	Greater Consumption of Coffee is Associated with Reduced Odds of Multiple Sclerosis (S45.004) 2015 ·Neurology ·Ellen M. Mowry, Anna Karin Hedström, Milena Gianfrancesco, Xiaorong Shao, Catherine Schaefer, Lisa F. Barcellos, Tomas Olsson, Lars Alfredsson	2
19	Multiple sclerosis patients differ from healthy controls on antioxidant and anti-inflammatory nutrients from self-reported diet history (P2.209) 2015 ·Neurology ·Sandra D. Cassard, Pavan Bhargava, Sonya Steele, (unknown), Emmanuelle Waubant, Ellen M. Mowry	0
20	Incidental MRI anomalies suggestive of multiple sclerosis 2008 ·Neurology ·Darin T. Okuda, Ellen M. Mowry, A. Beheshtian, Emmanuelle Waubant, Sergio E. Baranzini, Douglas S. Goodin, S L Hauser, Daniel Pelletier	392

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact